TAM
AMPH icon

Tucker Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Tucker Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,956
Closed -$1.73M – 1653
2023
Q4 		$1.73M Sell
27,956
-994
-3% -$52.2K 0.43% 24
2023
Q3 		$1.33M Buy
28,950
+1,148
+4% +$62.6K 0.36% 23
2023
Q2 		$1.6M Sell
27,802
-3,870
-12% -$172K 0.46% 21
2023
Q1 		$1.19M Buy
+31,672
New +$1.04M 0.36% 22

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Tucker Asset Management's AMPH Position: Q1 2024 in Review

Tucker Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 27,956 shares — an estimated $1.73M sold.

Tucker Asset Management first reported a position in AMPH in Q1 2023 and held it in 4 quarters. The position peaked at $1.73M in Q4 2023. 271 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • Tucker Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Tucker Asset Management sold 27,956 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $1.73M.
  • Tucker Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Tucker Asset Management's Amphastar Pharmaceuticals position peaked at $1.73M in Q4 2023.
  • 271 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Tucker Asset Management's 13F filing for Q1 2024, filed 9 Aug 2024.